Harnessing the power of precision medicine for the treatment of colorectal cancer

Join us as two experts in gastrointestinal oncology respond to questions from the oncology community on the role of biomarker-targeted therapies in personalizing treatment decisions in patients with CRC.
In Module 1, they explore biomarker-led patient identification, current treatment options and considerations for anti-EGFR rechallenge.
In Module 2, they discuss the role of biomarkers in treatment sequencing and associated practical challenges, alongside emerging treatments and indications of interest.
Watch now: touchoncologyime.org/harnessi...
Register today to stay informed about Module 2:
touchoncology.com/your-free-1...
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.